Published in
Taylor and Francis Group, Leukemia & Lymphoma, p. 1-9, 2024
DOI: 10.1080/10428194.2024.2363430
Links
Tools
Cytarabine dose intensification improves survival in older patients with secondary/high-risk acute myeloid leukemia in matched real-world versus clinical trial data
Journal article published in 2024 by
Christoph Abé 
,
Jaana Keto ,
Mathias Lilja ,
Mie Konradsen ,
Johan Mesterton ,
Martin Höglund,
Vladimir Lazarevic ,
Sören Lehmann,
Gunnar Juliusson
,
Jaana Keto ,
Mathias Lilja ,
Mie Konradsen ,
Johan Mesterton ,
Martin Höglund,
Vladimir Lazarevic ,
Sören Lehmann,
Gunnar Juliusson
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 